1,3-dipropyl-8-cyclopentylxanthine has been researched along with hexamethonium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nekooeian, AA; Tabrizchi, R | 1 |
Breadon, EL; Lindsay, KE; Prior, C | 1 |
Alves-Do-Prado, W; Bando, E; Bornia, EC; Machinski, M; Pereira, MW | 1 |
3 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and hexamethonium
Article | Year |
---|---|
Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats.
Topics: Adenosine; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cobalt Radioisotopes; Ganglionic Blockers; Heart Rate; Hemodynamics; Hexamethonium; Male; Microspheres; Phenethylamines; Phenylephrine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Receptors, Purinergic P2; Stroke Volume; Tin Radioisotopes; Vascular Resistance; Xanthines | 1996 |
Modulation by presynaptic adenosine A1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse.
Topics: Adenine; Animals; Enzyme Inhibitors; Hexamethonium; Mice; Mice, Inbred BALB C; Neuromuscular Blockade; Neuromuscular Junction; Nicotinic Antagonists; Purinergic P1 Receptor Antagonists; Receptors, Presynaptic; Receptors, Purinergic P1; Tetany; Vecuronium Bromide; Xanthines | 1997 |
Presynaptic M1, M2, and A1 receptors play roles in tetanic fade induced by pancuronium or cisatracurium.
Topics: Animals; Atracurium; Diamines; Electric Stimulation; Hexamethonium; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Skeletal; Neuromuscular Nondepolarizing Agents; Nicotinic Antagonists; Pancuronium; Phrenic Nerve; Pirenzepine; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Xanthines | 2009 |